YOUNG AGE UNDER 60 YEARS IS NOT A CONTRAINDICATION TO TREATMENT WITH DEFINITIVE DOSE ESCALATED RADIOTHERAPY FOR PROSTATE CANCER

BACKGROUND: It is widely believed that younger prostate cancer patients are at greater risk of recurrence following radiotherapy (RT). METHODS: From 1992–2007, 2168 (395 age ≤60) men received conformal RT alone for prostate cancer at our institution (median dose = 76 Gy, range:72–80). Multivariable...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Klayton, Tracy L., Ruth, Karen, Horwitz, Eric M., Uzzo, Robert G., Kutikov, Alexander, Chen, David Y.T., Sobczak, Mark, Buyyounouski, Mark K.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3225561/
https://ncbi.nlm.nih.gov/pubmed/21889222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2011.07.022
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires